- Home
- RWT vs VIR Comparison
RWT vs VIR Comparison
Compare RWT & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RWT | VIR |
|---|---|---|
| Founded | 1994 | 2016 |
| Country | United States | United States |
| Employees | 351 | 367 |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 707.5M | 1.5B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | RWT | VIR |
|---|---|---|
| Price | $5.30 | $8.90 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 7 |
| Target Price | $6.82 | ★ $19.43 |
| AVG Volume (30 Days) | 1.1M | ★ 1.4M |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | ★ 12.83% | N/A |
| EPS Growth | N/A | ★ 17.49 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $68,556,000.00 |
| Revenue This Year | $26.59 | $270.22 |
| Revenue Next Year | $22.21 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.00 | $4.16 |
| 52 Week High | $6.97 | $11.66 |
Technical Indicators
Market Signals| Indicator | RWT | VIR |
|---|---|---|
| Relative Strength Index (RSI) | 38.91 | 41.26 |
| Support Level | $5.04 | $8.47 |
| Resistance Level | $5.39 | $10.29 |
| Average True Range (ATR) | 0.14 | 0.42 |
| MACD | -0.02 | -0.15 |
| Stochastic Oscillator | 25.00 | 18.91 |
Price Performance
Historical ComparisonAbout RWT Redwood Trust Inc.
Redwood Trust Inc is a specialty finance company focused on several distinct areas of housing credit. The company delivers customized housing credit investments to a diverse mix of investors through securitization platforms, whole-loan distribution activities, and its publicly traded securities. The company has four reportable segments: Sequoia Mortgage Banking, CoreVest Mortgage Banking, Redwood Investments, and Legacy Investments. Maximum revenue is generated from the Sequoia Mortgage Banking segment, comprising a mortgage loan conduit that acquires residential consumer loans from third-party originators for subsequent sale to whole loan buyers, securitization through its SEMT private-label securitization program, or transfer into its Redwood Investments portfolio.
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.